Cross-border advisory Checkmate Capital Group specializes in international licensing opportunities and cross-border transactions across biotech, agtech, waste & energy tech, presenting a sales angle to firms seeking market expansion or licensing deals in APAC and North America.

Operational scale signal With a lean team of 2-10 employees yet a track record of high-profile roles at Morgan Stanley, BlackRock, UBS and more, the firm can be positioned as a boutique advisory partner offering nimble, specialized services to mid-market clients seeking strategic advisory without large overhead.

Recent collaboration momentum Recent partnerships and investments, including Armstrong Asia MOU for cross-border life sciences and a 1M preferred equity investment in Precision Livestock Technologies, indicate active deal flow and potential for co-investment or advisory roles in technology-enabled sectors.

Sector focus ripe Active emphasis on biotech, agtech, waste tech and energy tech aligns with growth sectors and sustainability trends, enabling targeted introductions to potential corporate customers, funding partners, and licensing opportunities in both mature and emerging markets.

Digital capability leverage Utilization of mainstream platforms (Wix, WordPress, Google Cloud, Microsoft 365) suggests scalable digital presence and client delivery capabilities; this supports outreach campaigns, content marketing, and virtual advisory engagements to speed deal sourcing.